Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Emmaus Life Sciences, Inc. | v394886_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 19, 2014
CNS RESPONSE, INC.
(Exact name of Company as specified in its charter)
| Delaware | 001-35527 | 87-0419387 |
| (State or other | (Commission File No.) | (I.R.S. Employer |
| jurisdiction of | Identification No.) | |
| incorporation) |
85 Enterprise, Suite 410
Aliso Viejo, CA 92656
(Address of principal executive offices)
(949) 420-4400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events |
On November 19, 2014, CNS Response, Inc. provided a submission for the record to the House Committee on Veterans' Affairs, Subcommittee on Health, for a legislative hearing in consideration of H.R. 5059, the Clay Hunt Suicide Prevention for American Veterans Act. The submission for the record included interim results, based on the first 10% of trial enrollment, of the Walter Reed PEER Trial. The interim results demonstrated statistical significance and were as follows:
When physicians used predictive analytics in the form of PEER information to establish a treatment strategy:
| · | 75% greater improvement in Suicidality scores |
| · | 144% greater improvement in Depression scores |
| · | 139% greater improvement in Post-Traumatic Stress Disorder (PTSD) scores |
| · | 43% more patients remained in treatment, with more than 50% improvement in treatment efficiency |
A copy of the submission for the record is attached hereto as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits |
The following exhibit is filed with this report:
| Exhibit No. | Description |
| 99.1 | Submission for the record provided by CNS Response, Inc. to the House Committee on Veterans Affairs', Subcommittee on Health on November 19, 2014 |
SIGNATURES
Pursuant to the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CNS Response, Inc. | |||
| By: | /s/ Paul Buck | ||
| November 20, 2014 | Paul Buck | ||
| Chief Financial Officer | |||